Diabetic macular edema
Conditions
Interventions
Sponsors
Tianjin Medical University Eye Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Age >=18 years, no gender restriction; 2. Diagnosed with diabetic macular edema by Optical Coherence Tomography (OCT), with central subfield thickness (CST) greater than 300 µm; 3. Meets treatment indications and has received faricimab (6.0 mg) treatment; 4. Best corrected visual acuity (BCVA): 20/40 to 20/320; 5. Stable diabetes control (HbA1c <=10%).
Exclusion criteria
Exclusion criteria: 1. Received treatment with other anti-VEGF drugs (such as ranibizumab or aflibercept) within the past 3 months; 2. Presence of other eye diseases (such as retinal vein occlusion, uveitis) affecting the retina; 3. Unstable systemic diseases (such as uncontrolled hypertension, severe renal insufficiency); 4. No aqueous humor sampling was performed before or after treatment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Central Subfield Thickness, CST;Best-Corrected Visual Acuity, BCVA; | — |
Countries
China
Contacts
Public ContactBincui Cai
Tianjin Medical University Eye Hospital
Outcome results
None listed